TollB-001

· Toll Biotech Co. Ltd. (Beijing)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TollB-001, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis [Phase 2]